Management of intravenous sedation for the elderly patients with progressed dementia during dental treatment- a comparison between midazolam and dexmedetomidine

Management of intravenous sedation for the elderly patients with progressed dementia during dental treatment- a comparison between midazolam and dexmedetomidine - Intravenous sedation for the progressed dementia

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000036530

Enrollment

Registered

2019-04-16

Start date

2019-04-16

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

dementia

Interventions

midazolam dexmedetomidine

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: with dementia >=60 years old

Exclusion criteria

Exclusion criteria: without dementia <60 years old

Design outcomes

Primary

Measure	Time frame
The cerabral blood flow and EEG during intravenous sedation	—

Secondary

Measure	Time frame
The cognitive function and swallowing function at pre- and post-sedation The nutrition and body composition	—

Countries

Japan

Contacts

Public ContactYoshinari Morimoto

Graduate School of Dentistry, Kanagawa Dental University Department of Critical Care Medicine and Dentistry

morimoto@kdu.ac.jp+819059605429

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026